Recombinant Mycobacterium Tuberculosis Fusion Protein

Recombinant Mycobacterium Tuberculosis Fusion Protein

Products and Business Services
Recombinant Mycobacterium Tuberculosis Fusion Protein
Recombinant Mycobacterium Tuberculosis Fusion Protein

Information

C-TST is a new diagnose method to detect Mtb infectionfor,which uses antigen-specific (ESAT6 & CFP10) immune response, same with the principle of action used in IGRAs.(1)Suitable for Large Scale LTBI Screening; (2)Non Cross-React with BCG Vaccine; (3)WHO Guideline Recommended; (4) Easy Use, Low Cost;
Distribution Areas
OceaniaNorth America (USA, Canada)AfricaMiddle East Region (e.g. UAE)Central America (e.g. Mexico)East Asia (e.g. China, Japan, Korea)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied From
China
Main Categories
Biopharmaceutical Products

Join the event!

See all the content and easy-to-use features by logging in or registering!